Caduet in an Untreated Subject Population
Public ClinicalTrials.gov record NCT00332761. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An 8-Week Randomized, Double-Blind, Placebo-Controlled Trial Examining The Efficacy And Safety Of Caduet® In Simultaneously Achieving Blood Pressure And Lipid Goals In An Untreated Hypertensive And Dyslipidemic Subject Population. (CUSP - Caduet in Untreated Subject Population)
Study identification
- NCT ID
- NCT00332761
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Industry
- Enrollment
- 220 participants
Conditions and interventions
Conditions
Interventions
- Caduet Drug
Drug
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2006
- Primary completion
- Not listed
- Completion
- Aug 31, 2007
- Last update posted
- Jan 26, 2021
2006 – 2007
United States locations
- U.S. sites
- 34
- U.S. states
- 17
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Jonesboro | Arkansas | 72401 | — |
| Pfizer Investigational Site | Little Rock | Arkansas | 72204 | — |
| Pfizer Investigational Site | Garden Grove | California | 92843 | — |
| Pfizer Investigational Site | Long Beach | California | 90806 | — |
| Pfizer Investigational Site | Tustin | California | 92780 | — |
| Pfizer Investigational Site | Aventura | Florida | 33180 | — |
| Pfizer Investigational Site | Fort Lauderdale | Florida | 33308 | — |
| Pfizer Investigational Site | Miami | Florida | 33137 | — |
| Pfizer Investigational Site | Pembroke Pines | Florida | 33027 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30309 | — |
| Pfizer Investigational Site | Decatur | Georgia | 30033 | — |
| Pfizer Investigational Site | Bossier City | Louisiana | 71111 | — |
| Pfizer Investigational Site | Fair Haven | Michigan | 48023 | — |
| Pfizer Investigational Site | Livonia | Michigan | 48152 | — |
| Pfizer Investigational Site | Jackson | Mississippi | 39201 | — |
| Pfizer Investigational Site | Jackson | Mississippi | 39202 | — |
| Pfizer Investigational Site | Excelsior Springs | Missouri | 64024 | — |
| Pfizer Investigational Site | Berlin | New Jersey | 08009 | — |
| Pfizer Investigational Site | Elizabeth | New Jersey | 07202 | — |
| Pfizer Investigational Site | Princeton | New Jersey | 08540 | — |
| Pfizer Investigational Site | South Bound Brook | New Jersey | 08880 | — |
| Pfizer Investigational Site | Binghamton | New York | 13901 | — |
| Pfizer Investigational Site | Monroe | North Carolina | 28112 | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45236 | — |
| Pfizer Investigational Site | Dayton | Ohio | 45406-5144 | — |
| Pfizer Investigational Site | Eugene | Oregon | 97404 | — |
| Pfizer Investigational Site | Bensalem | Pennsylvania | 19020 | — |
| Pfizer Investigational Site | Kingsport | Tennessee | 37660 | — |
| Pfizer Investigational Site | Beaumont | Texas | 77702 | — |
| Pfizer Investigational Site | Colleyville | Texas | 76034 | — |
| Pfizer Investigational Site | Houston | Texas | 77030 | — |
| Pfizer Investigational Site | Temple | Texas | 76502 | — |
| Pfizer Investigational Site | Norfolk | Virginia | 23510 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00332761, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 26, 2021 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00332761 live on ClinicalTrials.gov.